AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 12.9 |
Market Cap | 228.32M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -6.64 |
PE Ratio (ttm) | -2.35 |
Forward PE | n/a |
Analyst | Buy |
Ask | 16.54 |
Volume | 37,396 |
Avg. Volume (20D) | 101,691 |
Open | 15.85 |
Previous Close | 15.92 |
Day's Range | 15.49 - 15.89 |
52-Week Range | 15.40 - 29.12 |
Beta | undefined |
About ANIK
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...
Analyst Forecast
According to 2 analyst ratings, the average rating for ANIK stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 57.15% from the latest price.
Next Earnings Release
Analysts project revenue of $29.00M, reflecting a -32.51% YoY shrinking and earnings per share of 0.09, making a 80.00% increase YoY.
2 months ago · seekingalpha.com
Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call TranscriptAnika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Matt Hall - Director, Corporate Development and IR Cheryl Blanchard - Presiden...